United States · Funded startup

Who invested in Kepley BioSystems

One round we have observed, with the 3 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Funding summaryUpdated 26 Oct 2026

$1.0Mraised across 1 round since 2022, from 1 source

Latest round
Grant, $1.0MDec 2022
Investors
3
See who backed them

The rounds

  1. Dec 2022

Founders and team

From Kepley BioSystems's own website: 1 founder, 3 on the team.

Terry E. BradyCo-founder, Business Development and Innovation
  • Lee RobertsonDirector of Scientific Communications and Operations
  • Rachel Tinker-Kulberg PhDDirector of Research and Development
  • Financial AdvisorTeam

AdvisersBob BarryDavid PhillipsRegulatory Advisor

Everyone who backed them

Missing a round, or an investor who was in one? Tell us.

Quick answers about Kepley BioSystems

Who invested in Kepley BioSystems?

Kepley BioSystems's investors include National Science Foundation, Small Business Innovation Research and North Carolina Biotechnology Center.

How much has Kepley BioSystems raised?

Kepley BioSystems has raised $1.0M across 1 round since 2022.

When did Kepley BioSystems last raise?

Kepley BioSystems's most recent round was a Grant of $1.0M in Dec 2022.

What was Kepley BioSystems's biggest round?

Its most recent round, $1.0M in Dec 2022, is also its largest on record.

Who backed Kepley BioSystems first?

Kepley BioSystems's first round on record, in Dec 2022, was backed by National Science Foundation, Small Business Innovation Research and North Carolina Biotechnology Center.

What stage is Kepley BioSystems at?

Kepley BioSystems's latest named round is a Grant, in Dec 2022.

Where is Kepley BioSystems based?

Kepley BioSystems is based in the United States.

Companies like Kepley BioSystems

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.